
INDIANAPOLIS, June 18 (UPI) -- Eli Lilly and Co. said the U.S. Food and Drug Administration has approved duloxetine HCl, marketed under the name Cymbalta, for fibromyalgia.
The Indianapolis drug maker said Cymbalta is the first serotonin-norepinephrine reuptake inhibitor proven to give relief to patients with the pain disorder.
"The FDA approval of Cymbalta for the management of fibromyalgia is another important step in the efforts to ensure that people with fibromyalgia will have the availability of effective medications to help reduce the chronic, widespread pain of this life-altering disorder," Lynne Matallana, president of the National Fibromyalgia Association, said in a statement.
Cymbalta was previously approved for the management of diabetic peripheral neuropathic pain, the treatment of major depressive disorder and generalized anxiety disorder in adults age 18 years and older, Eli Lilly said.
|
|
|
|
|
|
| Additional Science News Stories | |
BEL AIR, Md., June 1 (UPI) --
A student at Morgan State University in Baltimore admitted to killing a fellow student and eating some of his organs, a sheriff said.
|
PARIS, June 1 (UPI) --
Canadian pop star Justin Bieber passed out shortly after hitting his head by walking into a glass wall backstage at a Paris concert, TMZ reported.
|
MIAMI, June 1 (UPI) --
U.S. forecasters say a new statistical model will help determine a hurricane's strength and size as the official 2012 Atlantic hurricane season gets under way.
|
Officer inadvertently shoots wife in butt … Littering case over dollar dropped … Man running as VoteforEddie.com … Volunteers rescue injured eaglet … Watercooler stories from UPI.
|
| Stories | Photos | People | Comments |
View Caption